Companies: 10,795·Total market cap: $144.5T
Anavex Life Sciences Corp.

Anavex Life Sciences Corp.

AVXLNASDAQHealthcare● Active
$2.57
$-0.25(-8.87%)
Market Cap$238166418
P/E Ratio
52W High$13.99
52W Low$2.56
Overview

Anavex Life Sciences Corp. (AVXL) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · AVXL · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.46avxl eps ttm · avxl earnings per shareEarnings history
PE Ratio (TTM)avxl pe ratio ttm · avxl price to earningsPE Ratio deep dive
Revenue (TTM)0.00avxl revenue ttm · avxl annual revenueFull revenue history
Dividend YieldNo Dividenddoes avxl pay dividends · avxl dividend yieldDividend history
Shares Outstanding85.3Mavxl shares outstanding · avxl floatShares outstanding history
Next EarningsJun 9, 2026Est.avxl earnings date · avxl next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
anavex life sciences corp. revenue · avxl revenue 2025
FY 2025Net Income-$46.4M▼ 7.85% YoY
202320242025
anavex life sciences corp. net income · avxl profit 2025
FY 2025EPS$-0.54▼ 3.85% YoY
202320242025
avxl eps · anavex life sciences corp. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$39.9MEPS: $-0.46View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy13 analystsis avxl a buy · avxl analyst rating
Strong Buy
0
Buy
11
Hold
2
Sell
0
Strong Sell
0
12-Month Price Target
$11.00Low
$2.57Current
$11.00Avg Target328.02% upside
$11.00High
avxl price target · avxl 12 month forecast

Total: 13 · Buy rate: 84.6%

The AVXL analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month price target is $11.00, representing +328.02% upside from the current price of $2.57.

Stock Performance

Full History
1D-8.87%
1W-5.86%
1M-20.19%
3M-44.73%
YTD-27.81%
1Y-67.59%
5Y-83.13%

About Anavex Life Sciences Corp.

CEOChristopher U. Missling
IPO DateAug 2, 2006
Employees42
CountryUS
Websiteanavex.com

Anavex Life Sciences Corp. a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidat…

what is anavex life sciences corp. · avxl stock overview · anavex life sciences corp. company profile · who is anavex life sciences corp. ceo · avxl NASDAQ · anavex life sciences corp. headquarters · anavex life sciences corp. business segments

About Stock Overview & Key Data

Anavex Life Sciences Corp. (AVXL) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Aug 2, 2006. As of the latest trading session, AVXL stock price is $2.57, with a market capitalization of $238.2M. The stock has returned -67.59% over the past 12 months and -27.81% year-to-date.

According to 13 Wall Street analysts, the consensus rating for Anavex Life Sciences Corp. stock is Buy, with an average 12-month price target of $11.00. In fiscal year 2025, Anavex Life Sciences Corp. reported revenue of — and net income of -$46.4M. For detailed data — including Anavex Life Sciences Corp. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Anavex Life Sciences Corp. (AVXL) stock price is $2.57. The stock is traded on NASDAQ under the ticker symbol AVXL. The 52-week range is $2.56 – $13.99.

AVXL stock priceAVXL quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice